+
Site Tour

Case Parade | Tricuspid focus

Three intriguing cases, each highlighting unexpected challenges encountered during tricuspid valve interventions.

Watch on Demand videos on AV Valves Summit 2024

Related Videos

Case Transmission | Tricuspid focus

Screening Transmission | Mitral focus

MitraClip - AVVS 1 year 1 minute Mitral - Video

AV Valves Summit 2024 | Closing of Day 1

TriClip™: Device features

PremiClose 2024: Pediatric cardiologist view

LAAO Summit - LAAO with risk of leak

AV VALVES 2023: Fast Forward 20 Years

AV VALVES 2023: Trending Topics – Timing

AV VALVES 2023: Trending Topics – QoL

Anatomical overview of the heart

PremiClose 2024: Nenonatologist view

TRENDING TOPICS

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

CONNEXT


HUB
RELATED RESOURCES

Amplatzer™ Septal Occluder (ASO) technical brochure

Clinical insights: Amulet™

The Amulet IDE Trial

Amplatzer™ Amulet™ LAA Occluder

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit 2023: CT

AV VALVES 2023: Live Case – TEER

AV VALVES 2023: Morphology

LAAO Summit - Pre-procedural imaging

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline